Before We Start
A drug with a narrow margin between therapeutic and toxic
Digoxin is one of the oldest cardiac medications still in use — derived from the foxglove plant, used for centuries for heart failure and atrial fibrillation. It strengthens the heart's contractions and slows the rate. Done right, it improves quality of life. Done wrong, it kills.
What makes digoxin uniquely dangerous is its narrow therapeutic index — the difference between a therapeutic dose and a toxic dose is very small. The blood level that helps the heart is uncomfortably close to the level that poisons it. This is why digoxin requires more nursing vigilance than almost any other cardiac medication.
💡 What Does Digoxin Actually Do?
Digoxin inhibits the Na/K ATPase pump in cardiac cells. This raises intracellular sodium, which increases intracellular calcium — calcium is what makes heart muscle contract. More calcium = stronger contractions. Digoxin also increases vagal tone — slowing the SA and AV nodes, reducing heart rate and controlling ventricular rate in atrial fibrillation. Two mechanisms, two therapeutic effects: stronger pump, slower rate.
Recognizing Toxicity
Early signs, late signs, and the visual clue that is impossible to forget
Early Toxicity — GI Signs
The gut speaks first when digoxin levels rise
The first signs of digoxin toxicity are almost always gastrointestinal. The drug stimulates the chemoreceptor trigger zone in the brainstem.
Early GI symptoms:
• Nausea — persistent, not related to meals
• Vomiting
• Anorexia — patient refuses meals, "nothing sounds good"
• Abdominal pain and diarrhea
Clinical reflex: A patient on digoxin who starts refusing meals and reports nausea should have their digoxin level checked immediately — not assumed to have a GI illness. GI symptoms in a digoxin patient are toxicity until proven otherwise.
Who is most at risk:
• Elderly patients — decreased renal clearance, digoxin accumulates
• Renal failure — digoxin is renally excreted; if kidneys fail, levels rise
• Hypokalemia — low potassium makes cardiac cells MORE sensitive to digoxin toxicity (they compete for the same Na/K pump site)
• Patients on amiodarone — amiodarone increases digoxin levels by up to 100%
💊 "Nausea + digoxin = check the level." Never attribute GI symptoms to "just a bug" in a digoxin patient without checking the level and the potassium. Both.
Late Toxicity — Visual Changes
Yellow-green halos — the unforgettable digoxin sign
As toxicity progresses, it affects vision. Patients begin seeing yellow-green halos around lights, or describe a yellow tint to everything (xanthopsia). Objects may appear blurred. Lights may have halos.
Why this happens: Digoxin affects the retina and optic nerve through the same Na/K pump inhibition that affects cardiac cells.
The historical footnote: The painter El Greco (1541–1614) painted figures in elongated, yellow-tinged, haloed compositions. Some art historians and physicians have proposed he was experiencing chronic digoxin toxicity from digitalis-containing herbal remedies of his era — and literally painted what he saw. Whether true or not, it makes this symptom unforgettable.
Ask every digoxin patient: "Any changes in your vision? Any halos around lights?" A patient who says "everything looks a little yellow" needs a digoxin level drawn immediately.
💊 El Greco's yellow-haloed paintings may be the most memorable NCLEX study aid ever created — not intentionally, but effectively. Digoxin toxicity = yellow-green halos. You will never forget it.
Cardiac Toxicity — The Deadly Phase
Bradycardia, heart block, and life-threatening arrhythmias
At toxic levels, digoxin causes the very cardiac problems it is supposed to treat.
Cardiac signs of toxicity:
• Bradycardia — HR below 60, sometimes severely low (HR 30–40 possible)
• AV blocks — first, second, and third degree
• PVCs — especially bigeminy (alternating normal beat and PVC) — red flag for toxicity
• Ventricular tachycardia and fibrillation at severe toxic levels
• "Regularization" of A-fib — if a patient in A-fib suddenly has a very regular rhythm, it may mean complete heart block with a junctional escape rhythm
Classic ECG finding: PVCs in a digoxin patient — especially bigeminy — is a toxicity red flag until proven otherwise.
💊 "Digoxin toxicity causes the arrhythmias it treats." The drug that was controlling A-fib rate is now causing dangerous bradycardia and heart blocks. Apical pulse before every dose and telemetry monitoring are not optional — they catch this before it becomes fatal.
The Numbers to Know
Therapeutic level, hold parameter, and the potassium connection
Therapeutic Level: 0.5–2.0 ng/mL
Lower is often better — and draw timing matters
Normal therapeutic level: 0.5–2.0 ng/mL. Toxic above 2.0 ng/mL. Current evidence suggests 0.5–0.9 ng/mL is associated with best outcomes in heart failure — higher levels add toxicity risk without added benefit.
Blood draw timing: Must be drawn at least 6–8 hours after the last dose — ideally just before the next dose (trough). Drawing too soon gives a falsely elevated level that looks like toxicity when it is not.
Hold Parameter: Apical HR below 60
One full minute, apical — not radial
Before every digoxin dose: apical pulse for one full minute. Hold and notify provider if below 60 bpm.
Why apical and why a full minute: Digoxin patients often have atrial fibrillation — an irregularly irregular rhythm. Counting 15 seconds and multiplying misses irregularity. A full 60-second apical count is the standard of care.
The Potassium Connection
Low potassium + digoxin = toxicity even at normal levels
Potassium and digoxin compete for the same binding site on the Na/K ATPase pump. When potassium is low, digoxin binds more effectively — and more toxically — even when the digoxin level is within normal range.
Normal potassium: 3.5–5.0 mEq/L. Always check potassium before giving digoxin. If below 3.5 — notify provider. Potassium replacement may be needed first.
The dangerous combination: Digoxin + loop diuretic (furosemide). Loop diuretics cause potassium loss. Patients on both need consistent, careful potassium monitoring. A patient on furosemide and digoxin who has poor appetite (another source of potassium loss) and develops nausea is in serious trouble.
💊 "Loops lose potassium, and low potassium potentiates digoxin toxicity." This sentence belongs in every digoxin patient's care plan.
🏥 Clinical Scenario — Catching Digoxin Toxicity Before It Kills
Mrs. Dubois, 79 years old, on digoxin 0.125mg daily for heart failure with A-fib for 6 years. Admitted yesterday for a UTI. Started IV furosemide for fluid overload. This morning the nursing assistant reports she "barely touched breakfast and seemed confused."
GI flag
Assessment: Lethargic, oriented to person only, nausea since last night, not eating. On digoxin + furosemide (potassium-wasting). Digoxin toxicity on the differential immediately. This is not a bad morning.
Pulse
Apical pulse × 60 seconds: Rate 44, irregular. Her normal in A-fib is 68–74. HR 44 is significantly below baseline. Hold digoxin dose immediately. Contact provider.
Labs
Stat orders obtained: Digoxin level: 3.1 ng/mL (toxic — normal 0.5–2.0). Potassium: 2.8 mEq/L (low — furosemide washing out potassium). Both findings confirm toxicity and the mechanism: diuretic-induced hypokalemia potentiating digoxin toxicity.
Treat
Management: Digoxin held. Continuous cardiac monitoring. Potassium replacement IV (20 mEq KCl over 2 hours — never IV push). Digibind at bedside in case arrhythmias worsen. Furosemide dose adjusted. Recovery over 24–48 hours as digoxin clears renally.
📌 NCLEX Application
Priority assessment: "Before administering digoxin, which assessment does the nurse perform first?" → Apical pulse for one full minute. Hold if below 60.
Toxicity recognition: "A patient on digoxin reports nausea and seeing yellow halos around lights. What does the nurse do first?" → Hold the digoxin and notify the provider. Check digoxin level and potassium.
Potassium-digoxin interaction: "A patient on digoxin and furosemide has a potassium of 3.1. Which action does the nurse take?" → Notify provider before giving digoxin — hypokalemia increases toxicity risk even at therapeutic levels.
Antidote: "Which medication does the nurse prepare for severe digoxin toxicity with cardiac arrhythmias?" → Digoxin Immune Fab (Digibind).
Level draw timing: "When should the nurse draw a digoxin level?" → At least 6–8 hours after the last dose. Drawing too soon gives a falsely elevated result.
⚠️ The Trap — Regularization of A-Fib on Digoxin
A patient has been in A-fib — irregularly irregular — for years. The telemetry now shows a regular rhythm. The nurse thinks: great, the A-fib converted!
In a digoxin patient, sudden regularization of A-fib is a red flag — not good news.
What actually happened: Complete heart block has developed. The atria are still fibrillating, but no impulses cross the AV node. A junctional or ventricular escape pacemaker has taken over at a regular 40–60 bpm. The rhythm looks regular — but the patient is in complete heart block, a digoxin toxicity complication.
What to do: Treat as digoxin toxicity emergency. Hold digoxin. Notify provider. Prepare Digibind. Continuous monitoring. Possible pacing if hemodynamically unstable.
✓ Quick Self-Test
Answer before checking:
1. List the three phases of digoxin toxicity signs from earliest to most severe.
2. What is the therapeutic serum digoxin level?
3. At what apical heart rate do you hold digoxin?
4. Why does hypokalemia worsen digoxin toxicity?
5. What is the antidote for severe digoxin toxicity?
Answers:
1. Early: GI (nausea, vomiting, anorexia). Middle: Visual (yellow-green halos, color distortion, blurred vision). Late: Cardiac (bradycardia, AV blocks, PVCs/bigeminy, ventricular arrhythmias).
2. 0.5–2.0 ng/mL. Above 2.0 is toxic. For heart failure, lower is better (0.5–0.9 ng/mL preferred).
3. Hold if apical rate is below 60 bpm — assess for a full minute before every dose.
4. Potassium and digoxin compete for the same binding site on the Na/K ATPase pump. Low potassium means less competition — digoxin binds more, producing toxic effects even at a normal blood level.
5. Digoxin Immune Fab (Digibind) — antibody fragments that bind free digoxin molecules and remove them from circulation.